文献速递肝病消化道肿瘤与早癌

肝细胞癌中主干突变事件在瘤内和瘤间呈现极小的异质性

Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma.
PubMed 文献 · J Hepatol · 2017-08-24

通过对151份代表肝细胞癌多步发生过程的样本进行靶向测序和单核苷酸多态性阵列分析,研究发现TERT启动子突变、TP53和CTNNB1突变是早期病变中的主干事件,这些突变在大型肿瘤的不同区域以及原发与转移结节间广泛共享(>85%),支持单次活检足以捕获肝细胞癌主干突变的观点。

要点

  • TERT启动子突变(10.5%)和1号、8号染色体广泛拷贝数异常(3-7%)是异型增生结节中的主干门控事件,并维持于小肝癌。
  • 小肝癌中主干驱动事件包括TP53(23%)和CTNNB1(11%)突变,以及已知驱动基因的局灶扩增或缺失(6%)。
  • TERT、TP53和CTNNB1突变在大型肿瘤不同区域间约90%为普遍存在,在原发与转移肿瘤间85%保留。

核心结论

  • 早期阶段的主干事件(TERT、TP53、CTNNB1突变)在>85%的病例中普遍存在于同一肿瘤的不同区域以及原发与转移结节之间,支持单次活检足以捕获肝细胞癌主干突变。

研究设计与样本

  • 研究分析了151份代表肝细胞癌多步发生过程的样本,采用靶向测序和单核苷酸多态性阵列。

主要发现

  • 异型增生结节中TERT启动子突变频率为10.5%,1号和8号染色体广泛拷贝数异常频率为3-7%,这些主干门控事件在小肝癌中维持。
  • 小肝癌中TP53突变频率为23%,CTNNB1突变频率为11%,已知驱动基因的局灶扩增或缺失频率为6%。
  • TERT、TP53和CTNNB1突变是最常见的主干事件,至少一种存在于51%的小肝癌中。
  • 大型肿瘤不同区域间约90%的上述基因突变为普遍存在。
  • 多结节肝细胞癌中35%的患者存在肝内转移,原发与转移肿瘤间85%的TERT、TP53和/或CTNNB1突变保留。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: According to the clonal model of tumor evolution, trunk alterations arise at early stages and are ubiquitous. Through the characterization of early stages of hepatocarcinogenesis, we aimed to identify trunk alterations in hepatocellular carcinoma (HCC) and study their intra- and inter-tumor distribution in advanced lesions. METHODS: A total of 151 samples representing the multistep process of hepatocarcinogenesis were analyzed by targeted-sequencing and a single nucleotide polymorphism array. Genes altered in early lesions (31 dysplastic nodules [DNs] and 38 small HCCs [sHCC]) were defined as trunk. Their distribution was explored in: a) different regions of large tumors (43 regions, 21 tumors), and b) different nodules of the same patient (39 tumors, 17 patients). Multinodular lesions were classified as intrahepatic metastases (IMs) or synchronous tumors based on chromosomal aberrations. RESULTS: TERT promoter mutations (10.5%) and broad copy-number aberrations in chromosomes 1 and 8 (3-7%) were identified as trunk gatekeepers in DNs and were maintained in sHCCs. Trunk drivers identified in sHCCs included TP53 (23%) and CTNNB1 (11%) mutations, and focal amplifications or deletions in known drivers (6%). Overall, TERT, TP53 and CTNNB1 mutations were the most frequent trunk events and at least one was present in 51% of sHCCs. Around 90% of mutations in these genes were ubiquitous among different regions of large tumors. In multinodular HCCs, 35% of patients harbored IMs; 85% of mutations in TERT, TP53 and/or CTNNB1 were retained in primary and metastatic tumors. CONCLUSIONS: Trunk events in early stages (TERT, TP53, CTNNB1 mutations) were ubiquitous across different regions of the same tumor and between primary and metastatic nodules in >85% of cases. This concept supports the knowledge that single biopsies would suffice to capture trunk mutations in HCC. LAY SUMMARY: Trunk alterations arise at early stages of cancer and are shared among all malignant cells of the tumor. In order to identify trunk alterations in HCC, we characterized early stages of hepatocarcinogenesis represented by dysplastic nodules and small lesions. Mutations in TERT, TP53 and CTNNB1 genes were the most frequent. Analyses in more advanced lesions showed that mutations in these same genes were shared between different regions of the same tumor and between primary and metastatic tumors, suggesting their trunk role in this disease.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Torrecilla S, Sia D, Harrington AN, et al. Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma. J Hepatol. 2017. PMID: 28843658. doi:10.1016/j.jhep.2017.08.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。